Evercore ISI raised the firm’s price target on Abbott (ABT) to $140 from $138 and keeps an Outperform rating on the shares after the company reported organic growth of 6.9% in Q1 and the strength was “broad based” along with an overall EPS beat as earnings grew about 11%. In an environment where uncertainty is the dominating theme, the ability to protect the bottom-line should be appreciated, says the analyst, who calls Abbott “the perfect stock to weather macro uncertainty.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Early notable gainers among liquid option names on April 16th
- Abbott says seeing growth in Diagnostics unit everywhere except China
- Unusually active option classes on open April 16th
- Abbott says was considering raising EPS guidance prior to tariffs
- Abbott says well-positioned to mitigate impact of tariffs